Cysto-Conray II
NDC 0019-0862, Iothalamate meglumine, injection, from Liebel-Flarsheim Company LLC.
- Product NDC
- 0019-0862
- Status
- Listed
- Labeler
- Liebel-Flarsheim Company LLC
- Dosage form
- INJECTION
- Route
- URETERAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA017057
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0019-0862 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IOTHALAMATE MEGLUMINE172 mg/mL
Pharmacologic classes
Radiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0019-0862-50 | 00019086250 | 12 BOTTLE, GLASS in 1 BOX (0019-0862-50) / 250 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/8841ab4d-674d-4beb-88a5-13e35f6005ccMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0019-0862
Use it
Look up 0019-0862 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0019-0862 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0019-0862. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.